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Invasion in and translocation across enterocytes are major events during Campylobacter jejuni-induced enteritis in humans. C. jejuni in vitro
infection of cell monolayers typically results in loss of tight junction integrity, which could contribute to translocation. In the present study, we
wanted to investigate whether butyrate is able to confer protection to Caco-2 cells against C. jejuni invasion, thus reducing paracellular permeability
and limiting C. jejuni translocation. Protection of Caco-2 cells against C. jejuni invasion was assessed using a gentamicin protection assay. Trans-
well systems were used to investigate the impact of butyrate on translocation of C. jejuni across a Caco-2 monolayer and its effect on transepithelial
resistance during infection. Butyrate protected Caco-2 cells against C. jejuni invasion in a concentration-dependent manner. Differentiated Caco-2
cells were less susceptible to C. jejuni invasion than 3-d-old undifferentiated cells and higher concentrations of butyrate and longer incubation times
were needed to become refractive for invasion. C. jejuni translocation over Caco-2 monolayers was reduced when monolayers were treated with
butyrate and this was accompanied by an enhanced drop in transepithelial resistance. The present study showed that butyrate is able to protect
Caco-2 cells from two major virulence mechanisms of C. jejuni, namely invasion and translocation, but not from a decline in transepithelial
resistance.
Butyrate: Campylobacter jejuni: Caco-2 cells
Butyrate is an important product of bacterial fermentation
of dietary fibre in the colonic lumen, where it is consumed
as a primary energy source by the mucosa(1). It plays an
active role in gut health by its anti-inflammatory properties(2),
its ability to decrease paracellular permeability via modula-
tion of the tight junction proteins(3) and promotion of the
restoration and preservation of the gut barrier after
damage(4,5).
The pathogenesis of a Campylobacter jejuni infection,
currently one of the leading causes of food-borne bacterial
gastroenteritis, is associated with bacterial invasion in and
translocation over the intestinal epithelium(6,7) and disruption
of tight junctions(8). The mechanisms behind C. jejuni translo-
cation are paradoxical: both transcellular and paracellular
routes have been observed(9,10). A drop in transepithelial
resistance (TER) is noticed after prolonged infection times
and high inoculation doses(8,9). This TER drop is associated
with a re-localisation of occludin from an intercellular to an
intracellular location(8,11) and thus a disruption of the tight
junctions.
Because of the beneficial effects of butyrate on tight junc-
tion integrity and gut health, we investigated whether butyrate
could play a protective role during C. jejuni infection by
decreasing invasion and increasing tight junction integrity
resulting in decreased bacterial paracellular translocation.
Materials and methods
Cell culture and reagents
Caco-2 cells were used in the present study, because this cell
line is widely known for its ability to differentiate and its
capacity to form high columnar epithelial cells, closely resem-
bling intestinal epithelium(12). Caco-2 cells were cultured in
Dulbecco’s modified Eagle’s medium supplemented with
1% non-essential amino acids and 10% fetal calf serum, peni-
cillin (100U/ml) and streptomycin (0·1mg/ml) at 378C in a
5% CO2 atmosphere. All cell-culture reagents were from
Gibco (Invitrogen, Merelbeke, Belgium). For all experiments
twenty-four-well plates were used. Cells were seeded at
1 £ 105 cells/well in 1ml medium and allowed to attach and
reach confluency for 3 d. Cells were subjected to experiments
at two stages of differentiation: for undifferentiated cells, 3-d-
old monolayers were used, while for differentiated cells,
monolayers were used 17 d after seeding. Medium without
butyrate supplement was refreshed every 72 h, while
medium with butyrate was changed daily.
Bacterial strains and culture conditions
C. jejuni strain R-27456, kindly provided by Professor
Dr Peter Vandamme (Ghent University, Ghent, Belgium),
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was isolated from a patient suffering from bloody diarrhoea.
Bacteria were routinely cultured in Preston broth (Oxoid,
Basingstoke, Hants, UK) supplemented with Campylobacter-
specific growth supplements (SR117 and SR0232; Oxoid) at
428C under microaerobic conditions (5% O2; 5% CO2; 5%
H2; 85% N2). Escherichia coli DH5a and Salmonella
enteritidis 76SA88 were routinely cultured in Luria broth
at 378C. For enumeration of bacteria, C. jejuni, E. coli and
S. enteritidis were plated on modified charcoal cefoperazone
deoxycholate agar (mCCDA) plates, Luria agar plates and
brilliant green agar plates, respectively (Oxoid).
Cell number and cell viability assay
The number of Caco-2 cells available in the wells for bacterial
invasion was quantified, since inhibition of proliferation and
induction of apoptosis by butyrate could influence available
Caco-2 cell number(13,14). Cells were seeded on glass cover-
slips in a twenty-four-well plate at 1 £ 105 cells/well and
allowed to adhere and grow for 3 or 17 d. Cell numbers of
undifferentiated and differentiated cells, incubated with
0·0mM-, 2·5mM- or 5·0mM-butyrate for 24, 48 or 72 h were
enumerated microscopically after fixation with ice-cold
methanol and staining with Hoechst 33342 (10mg/ml; Sigma
Aldrich) for 10min at room temperature. Glass coverslips
were mounted and were examined through a Leica DM CB
microscope (Leica, Wetzlar, Germany) and cells of a mini-
mum of seven fields were counted.
Cell viability was assessed by using the colorimetric 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT;
Sigma, Bornem, Belgium) assay. Undifferentiated and differ-
entiated cells were treated with butyrate as described above.
MTT (0·5mg/ml) was added to the wells and cells were
further incubated for 3 h at 378C and 5% CO2. The reaction
was stopped by aspirating the medium and the formed forma-
zan crystals were dissolved by adding dimethylsulfoxide.
Absorbance was measured at 570 nm with a reference filter
at 690 nm.
Bacterial invasion assay
Caco-2 cells were seeded in twenty-four-well plates at 1 £ 105
cells/well and allowed to adhere and reach confluency for 3 d.
Because butyrate induces differentiation of the Caco-2 cell
layer(13), we used undifferentiated and differentiated mono-
layers to investigate the effect of an increased cellular differ-
entiation status on invasion susceptibility.
At 3 d and 17 d respectively, butyrate was added to the
medium at 0·0, 2·5 or 5·0mM for 24, 48 or 72 h. Thereafter,
cell cultures were washed and exposed to 8 £ 107 colony-
forming units (cfu) of C. jejuni suspended in cell-culture
medium without antibiotics and containing 0·0, 2·5 or
5·0mM-sodium butyrate. Plates were centrifuged for 10min
at 600 g at 378C to deposit bacteria to the surface of the mono-
layer. After 3 h, cell layers were washed and incubated with
gentamicin (100mg/ml) for 2 h to kill extracellular bacteria.
To enumerate intracellular bacteria, cells were lysed using
0·25% sodium deoxycholate and bacterial counts were per-
formed by titration on modified charcoal cefoperazone deoxy-
cholate agar (mCCDA) plates.
To examine the effect of butyrate on the C. jejuni ability to
invade Caco-2 cells, bacteria were grown in Preston broth
containing 5·0mM-butyrate for 18 h at 428C, under microaero-
bic conditions. The invasion assay was carried out on 3-d-old
Caco-2 cells, not exposed to butyrate.
Bacterial translocation and epithelial permeability assays
For these experiments, 1 £ 105 cells/well were seeded on the
apical side of Transwell polyester membrane filters (6·5mm
diameter inserts, 3·0mm pore size; Corning, Sigma Aldrich,
Bornem, Belgium) and left to differentiate for 17 d, after
which 0·0mM- or 5·0mM-sodium butyrate (Sigma Aldrich)
was added to the apical and basolateral chamber. After 48 h,
cells were washed and 2 £ 107 cfu of C. jejuni were added
to the apical chamber in cell culture medium without anti-
biotics and containing 0·0mM- or 5·0mM-sodium butyrate.
Well plates were centrifuged for 10min at 600 g at 378C.
E. coli DH5a and S. enteritidis 76SA88 served as negative
and positive controls respectively for bacterial translocation
and TER reduction(15). To enumerate translocated bacteria,
20ml samples were taken from the basolateral chamber at 0,
1, 3, 6 and 24 h after centrifugation and titrated. Resistance
was measured before and after inoculation using the
Endohme tissue resistance measurement chamber coupled
to an EVOMe epithelial voltohmmeter (World Precision
Instruments, Stevenage, Herts, UK).
Statistical analysis
All statistics were performed on at least three independent
assays. Results are given as mean values with their standard
errors. Significance was tested by the two-tailed Student’s
t test and P,0·05 was considered significant.
Results
The effect of butyrate on Caco-2 cell viability and cell number
Since butyrate is known to induce apoptosis in Caco-2 cells
and cell invasion by C. jejuni is influenced by the available
cell number in the monolayer, the effect of butyrate on cell
viability and number was evaluated. Treatment of undifferen-
tiated monolayers with butyrate resulted in decreased cell via-
bility after 72 h incubation with 2·5mM and 5·0mM (P,0·01)
as shown in Fig. 1(A). Differentiated cells showed a decreased
cell viability only after incubation with 5·0mM-butyrate
for 48 h and longer (Fig. 1(B)) (P,0·05), while 2·5mM had
no effect.
The cell number in the monolayer was slightly affected by
butyrate treatment. Cell number of undifferentiated mono-
layers (Fig. 1(A)) was only significantly reduced after 76 h
incubation with 5·0mM-butyrate and the percentage compared
with the untreated control was 63 (SEM 3) % (P,0·01). For
differentiated monolayers (Fig. 1(B)), 5·0mM significantly
reduced cell number after 24 and 48 h (86 (SEM 2) and 79
(SEM 3) % respectively compared with the untreated control
(P,0·01)).
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Butyrate protects undifferentiated Caco-2 cells better against
invasion of Campylobacter jejuni than differentiated cells
Treatment of the monolayer with butyrate caused a significant
decrease in C. jejuni invasion and this effect was concen-
tration dependent. This reduction was observed as soon as
24 h after pre-incubation of the monolayer with as little as
2·5mM-butyrate. Data for undifferentiated monolayers are
summarised in Fig. 2(A). No further decrease in invasion
was found when monolayers where incubated longer than
48 h (P.0·05).
Because butyrate enhances the differentiation of Caco-2
cells, we investigated the impact of the differentiation state
alone on C. jejuni invasion. In absence of butyrate, undifferen-
tiated 3-d-old Caco-2 monolayers were almost four times
more susceptible for C. jejuni invasion than 17-d-old differen-
tiated cells: 2·3 (SEM 0·3) £ 105 and 4·4 (SEM 1·1) £ 104 cfu/
ml (P,0·001) respectively, despite equal cell numbers in
the monolayer (average 1·44 (SEM 0·05) £ 106 cells/well and
1·43 (SEM 0·07) £ 106 cells/well for differentiated and undif-
ferentiated cells respectively; P.0·05). Even so, butyrate
still had a protective effect on 17-d-old Caco-2 cells, although
only concentrations of 5·0mM and incubation times of 48 h or
longer were needed. A butyrate concentration of 2·5mM had
no effect on C. jejuni invasion at all. Data are summarised
in Fig. 2(B).
No significant differences were found in the ability of
C. jejuni to invade the Caco-2 monolayer, when bacteria
were grown in the presence of 5·0mM-butyrate, compared
with C. jejuni grown in Preston broth alone (data not shown).
Butyrate reduces translocation of Campylobacter jejuni over
the Caco-2 cell monolayer, despite loss of transepithelial
resistance
Because of the marked decrease of C. jejuni invasion due to
butyrate treatment, we wondered if butyrate could also influ-
ence translocation of C. jejuni over Caco-2 cells. The addition
of 5·0mM-butyrate to the monolayer for a period of 48 h
resulted in a slight but still significant drop in TER (0·0mM-
butyrate: 1056 (SEM 34) V/cm2; 5·0mM-butyrate: 841 (SEM
78) V/cm2; P,0·01).
When C. jejuni was added to the apical chamber of buty-
rate-treated and -untreated differentiated monolayers seeded
in the Transwell system, bacteria were recovered from the
basolateral chamber after centrifugation. However, 24 h after
bacterial inoculation, approximately ten times less bacteria
were recovered: 1·3 (SEM 0·8) £ 105 cfu/ml for monolayers
treated with 5·0mM-butyrate, compared with 3·0 (SEM
1·5) £ 106 cfu/ml for monolayers not treated with butyrate
(P,0·05). Results are given in Fig. 3.
The addition of C. jejuni at 2 £ 107 cfu to the apical chamber
of untreated cells did not result in TER decrease (before inocu-
lation: 1056 (SEM 34) V/cm2; after inoculation: 1026 (SEM 87)
V/cm2; P.0·05). In contrast, when monolayers were inocu-
lated with C. jejuni after pre-treatment of the Caco-2 cells
with 5·0mM-butyrate for 48 h, a pronounced drop of TER
was observed 24 h after infection (before inoculation: 841
(SEM 78) V/cm2; after inoculation: 425 (SEM 53) V/cm2;
P,0·01).
No translocation or drop in TER was observed when both
butyrate-pre-treated and -untreated monolayers were inocu-
lated with E. coli DH5a, which served as a negative control.
When S. enteritidis was added to the monolayers, a drop in
Fig. 1. Effect of butyrate on cell viability and cell number after exposure to
2·5 mM- (n) or 5·0 mM-butyrate (A) for 24, 48 and 72 h, compared with the
untreated control (B) in (A) 3-d-old undifferentiated and (B) 17-d-old differen-
tiated Caco-2 cells. Cell viability was evaluated by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results are expressed
on the left axis as % of control (100 %). On the right axis, the cell number
after incubation for 24, 48 and 72 h with concentrations of 2·5 mM (X) or
5·0 mM (W) is given as % of control (100 %). Values are means calculated
from at least three different experiments, with standard errors represented by
vertical bars. Mean value was significantly different from that of the untreated
control: *P,0·05, **P,0·01.
Fig. 2. The percentages of invaded Campylobacter jejuni bacteria in (A) 3-d-
old undifferentiated and (B) 17-d-old differentiated Caco-2 cells, pre-treated
with 2·5 mM- (n) or 5·0 mM-butyrate (A) for 24, 48 or 72 h, compared with
untreated control (100 %, B). Values are means calculated from at least
three different experiments, with standard errors represented by vertical
bars. Mean value was significantly different from that of the untreated control:
*P,0·05, **P,0·01.
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TER was observed both in butyrate-treated and -untreated
monolayers after 6 h, which was accompanied with a massive
translocation of bacteria. Average TER loss for untreated cells
and treated cells was, respectively, 78 (SEM 4) and 90 (SEM 37)
V/cm2 (P.0·05), while translocation of bacteria over the
monolayer was 22 (SEM 4) £ 107 cfu/ml and 8 (SEM
1) £ 107 cfu/ml for the untreated control and 5·0mM-buty-
rate-treated monolayer respectively (P.0·05).
Discussion
The present study showed that butyrate can protect Caco-2
cells against the first steps of C. jejuni pathogenesis: invasion
and translocation. These effects could be attributed to a pro-
tective effect of butyrate on Caco-2 cells and not to an
effect on the pathogen itself regarding its invasive capabilities.
Butyrate protected Caco-2 cells from C. jejuni invasion in a
concentration-dependent manner and an incubation time of
24 h was sufficient. It has been described that butyrate inhibits
proliferation and induces apoptosis(13,14) and thus the observed
decrease in invasion could be the result of a reduced cell
number in the monolayer. However, in the case of undifferen-
tiated cells, the effect of butyrate on cell number and cell viabi-
lity could not explain these observations: the number and
viability of undifferentiated Caco-2 cells was only significantly
reduced from 72 and 48 h incubation with 5·0mM-butyrate
respectively, while the reduction of Campylobacter invasion
was observed as soon as 24 h after treatment with butyrate.
The reduced bacterial invasion might be largely explained by
the butyrate-induced cellular differentiation(13). This hypoth-
esis is supported by the finding that, in the absence of butyrate,
differentiated monolayers were four times less susceptible to
C. jejuni invasion than undifferentiated cells. A possible
mechanism of butyrate protection could be the decrease in
tyrosine phosphorylation observed during Caco-2 cell
differentiation(16). Indeed C. jejuni invasion has been shown
to depend on tyrosine phosphorylation of the host cell(17–19).
Butyrate still had a protective effect on differentiated mono-
layers, but only after a pre-treatment period of 48 h with
5·0mM-butyrate. This is in accordance with earlier obser-
vations that the differentiating monolayer loses its sensitivity
towards butyrate(20). The observed reduction of invasion of
Campylobacter coincided with a decreased cell viability and
it seems that, unlike undifferentiated cells, the protective
effect of butyrate can be at least partly be attributed to a
decrease in cell viability.
The second step in C. jejuni pathogenesis, namely transloca-
tion across the cell monolayer, was significantly reduced when
cells were treated with butyrate, despite a marked decrease
in TER. Although this drop suggests increased monolayer
permeability, it seems that tight junctions still displayed suffi-
cient integrity to prevent mass paracellular translocation of
C. jejuni. The decrease in TER combined with a pronounced
reduction of translocated bacteria thus favours the hypothesis
that translocation of C. jejuni is transcellular in nature and
that the observed reduction of translocation is caused by a
decreased susceptibility of the cell for C. jejuni invasion.
Butyrate is frequently associated with various health-promot-
ing functions, such as a decreased risk for colon cancer and irri-
table bowel syndrome. The present results suggest that butyrate
might protect from campylobacteriosis. The concentration of
butyrate can be increased by altering the composition of the
diet. Resistant starch and dietary fibres that escaped digestion
are the most important sources for fermentation by the colonic
anaerobic microbiota. Various feeding studies demonstrate the
ability of diet composition to alter SCFA concentrations in the
intestine. Rats that were fed a wheat-bran diet had increased
butyrate concentration compared with rats on a high-fermenta-
ble pectin diet(21). The distribution of butyrate depends on the
fermentability of fibres: the fermentation and absorption of
SCFA is very fast and highly fermentable fibres such as pectin
and oat bran are absorbed in the caecum and the proximal
colon, while the consumption of slowly fermentable fibres,
such as wheat bran, result in a consistently high butyrate level
in the distal region of the rat colon(22,23). It should be noted
that fast fermentable fibres still are able to contribute to intestinal
health and elevation in butyrate concentration, as demonstrated
by Hallert et al. (24). In their study, patients suffering from
ulcerative colitis were subjected to a diet consisting of 20 g diet-
ary fibre from oat bran and their faecal butyrate concentration
was significantly increased at the end of the trial. Since an
elevation of butyrate concentration due to slow-fermenting
fibres is most noticeable in the distal colon, and considering
the topology of C. jejuni infections(25,26), dietary fibres could
have a positive influence on C. jejuni-induced enteritis by redu-
cingC. jejuni invasion and translocation over the gut epithelium.
In conclusion, the present study illustrates that butyrate is
able to protect the Caco-2 monolayer from C. jejuni invasion
and translocation, correlating with enhanced cellular
differentiation. Since colonic butyrate concentrations depend
on dietary fibre, diet formulation may influence the outcome
of campylobacteriosis.
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Fig. 3. Campylobacter jejuni translocation over butyrate-pre-treated
monolayers. Monolayers were incubated with 0·0 mM- (O) or 5·0 mM-butyrate
(K) for 48 h. Values are means calculated from three different experiments,
with standard errors represented by vertical bars. * Mean value was
significantly different from that of the untreated control (P,0·05). cfu,
Colony-forming units.
Protection of Caco-2 cells by butyrate 483
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
References
1. Cummings JH (1981) Short chain fatty acids in the human
colon. Gut 22, 763–779.
2. Tedelind S, Westberg F, Kjerrulf M & Vidal A (2007) Anti-
inflammatory properties of the short-chain fatty acids acetate
and propionate: a study with relevance to inflammatory bowel
disease. World J Gastroenterol 13, 2826–2832.
3. Mariadason JM, Barkla DH & Gibson PR (1997) Effect of
short-chain fatty acids on paracellular permeability in Caco-2
intestinal epithelium model. Am J Physiol 272, 705–712.
4. Venkatraman A, Ramakrishna BS & Pulimood AB (1999) Buty-
rate hastens restoration of barrier function after thermal and
detergent injury to rat distal colon in vitro. Scand J Gastroen-
terol 34, 1087–1092.
5. Kanauchi O, Iwanaga T, Mitsuyama K, Saiki T, Tsuruta O,
Noguchi K & Toyonaga A (1999) Butyrate from bacterial fer-
mentation of germinated barley foodstuff preserves intestinal
barrier function in experimental colitis in the rat model. J Gas-
troenterol Hepatol 14, 880–888.
6. Russell RG, O’Donnoghue M, Blake DC Jr, Zulty J & DeTolla
LJ (1993) Early colonic damage and invasion of Campylobacter
jejuni in experimentally challenged infant Macaca mulatta. J
Infect Dis 168, 210–215.
7. Youssef M, Corthier G, Goossens H, Tancrede C, Henry-Amar M
& Andremont A (1987) Comparative translocation of entero-
pathogenic Campylobacter spp. and Escherichia coli from the
intestinal tract of gnotobiotic mice. Infect Immun 55, 1019–1021.
8. MacCallum A, Hardy SP & Everest PH (2005) Campylobacter
jejuni inhibits the absorptive transport functions of Caco-2 cells
and disrupts cellular tight junctions. Microbiology 151,
2451–2458.
9. Bras AM & Ketley JM (1999) Transcellular translocation of
Campylobacter jejuni across human polarised epithelial mono-
layers. FEMS Microbiol Lett 179, 209–215.
10. Monteville MR & Konkel ME (2002) Fibronectin-facilitated
invasion of T84 eukaryotic cells by Campylobacter jejuni
occurs preferentially at the basolateral cell surface. Infect
Immun 70, 6665–6671.
11. Chen ML, Ge Z, Fox JG & Schauer DB (2006) Disruption of
tight junctions and induction of proinflammatory cytokine
responses in colonic epithelial cells by Campylobacter jejuni.
Infect Immun 74, 6581–6589.
12. Hidalgo IJ, Raub TJ & Borchardt RT (1989) Characterization of
the human colon carcinoma cell line (Caco-2) as a model system
for intestinal epithelial permeability. Gastroenterology 96,
736–749.
13. Siavoshian S, Blottiere HM, Le Foll E, Kaeffer B, Cherbut C &
Galmiche JP (1997) Comparison of the effect of different short
chain fatty acids on the growth and differentiation of human
colonic carcinoma cell lines in vitro. Cell Biol Int 21, 281–287.
14. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E &
Lentze MJ (2003) Butyrate induced Caco-2 cell apoptosis is
mediated via the mitochondrial pathway. Gut 52, 94–100.
15. Sugita-Konishi Y, Ogawa M, Arai S, Kumagai S, Igimi S &
Shimizu M (2000) Blockade of Salmonella enteritidis passage
across the basolateral barriers of human intestinal epithelial
cells by specific antibody. Microbiol Immunol 44, 473–479.
16. Schwartz B, Lamprecht SA, Polak-Charcon S, Niv Y & Kim YS
(1995) Induction of the differentiated phenotype in human colon
cancer cell is associated with the attenuation of subcellular
tyrosine phosphorylation. Oncol Res 7, 277–287.
17. Biswas D, Niwa H & Itoh K (2004) Infection with Campylo-
bacter jejuni induces tyrosine-phosphorylated proteins into
INT-407 cells. Microbiol Immunol 48, 221–228.
18. Hu L, McDaniel JP & Kopecko DJ (2006) Signal transduction
events involved in human epithelial cell invasion by Campylo-
bacter jejuni 81-176. Microb Pathog 40, 91–100.
19. Wooldridge KG, Williams PH & Ketley JM (1996) Host signal
transduction and endocytosis of Campylobacter jejuni. Microb
Pathog 21, 299–305.
20. Mariadason JM, Velcich A, Wilson AJ, Augenlicht LH &
Gibson PR (2001) Resistance to butyrate-induced cell differen-
tiation and apoptosis during spontaneous Caco-2 cell differen-
tiation. Gastroenterology 120, 889–899.
21. Lupton JR & Kurtz PP (1993) Relationship of colonic luminal
short-chain fatty acids and pH to in vivo cell proliferation in
rats. J Nutr 123, 1522–1530.
22. McIntyre A, Young GP, Taranto T, Gibson PR & Ward PB
(1991) Different fibres have different regional effects on luminal
contents of rat colon. Gastroenterology 101, 1274–1281.
23. McIntyre A, Gibson PR & Young GP (1993) Butyrate pro-
duction from dietary fiber and protection against large bowel
cancer in a rat model. Gut 34, 386–391.
24. Hallert C, Bjorck I, Nyman M, Pousette A, Granno C &
Svensson H (2003) Increasing fecal butyrate in ulcerative colitis
patients by diet: controlled pilot study. Inflamm Bowel Dis 9,
116–121.
25. Peterson MC (1994) Clinical aspects of Campylobacter jejuni
infections in adults. West J Med 161, 148–152.
26. Fauchere JL, Veron M, Lellouch-Tubiana A & Pfister A (1985)
Experimental infection of gnotobiotic mice with Campylobacter
jejuni: colonisation of intestine and spread to lymphoid and reti-
culo-endothelial organs. J Med Microbiol 20, 215–224.
K. Van Deun et al.484
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
